American research and development subsidiary of the Chinese group Hansoh Pharmaceutical, founded in 2019 and based at Rockville in Maryland, one of the group's four research centres alongside Shanghai, Lianyungang and Changzhou. Carries out discovery and early development research on biologics and small molecules for the group, works on antibody drug conjugates and oncology and metabolic disease programmes, and supports clinical development and regulatory work in the United States.
Aucun commentaire disponible.
Laissez votre note & commentaire